Form 4 Filing for CLOVER HEALTH INVESTMENTS, CORP. /DE

This filing details transactions related to Class A Common Stock for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV). Conrad Wai, CEO of Counterpart Health, acquired 267,766 shares of Class A Common Stock on April 1, 2026, with a reported transaction price of $0.0. These shares represent restricted stock units (RSUs) that will vest over time, with 25% vesting on April 1, 2027, and the remainder vesting quarterly thereafter, fully vesting by April 1, 2030. Following this transaction, Mr. Wai has 1,193,377 shares directly held. Additionally, the filing reports 1,610,482 shares of Class A Common Stock held indirectly through a trust for the benefit of his family, of which he is a co-trustee.